```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4333 Introduced in House (IH)]

<DOC>

115th CONGRESS
  1st Session
                                H. R. 4333

   To provide for the issuance of a Lyme Disease Research Semipostal 
                                 Stamp.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            November 9, 2017

 Mr. Faso (for himself, Mr. Peterson, Mrs. Comstock, Ms. Shea-Porter, 
  Ms. Pingree, Mr. Moulton, Ms. Norton, Mr. Barletta, Mr. Lance, Ms. 
Stefanik, Mr. Sean Patrick Maloney of New York, Mr. Cohen, Mr. Keating, 
  Mr. Pocan, Ms. Lofgren, Mr. Espaillat, Mr. Katko, Mr. Smith of New 
 Jersey, Mr. King of New York, Mr. Courtney, Mr. Collins of New York, 
 Mr. Zeldin, and Mr. Donovan) introduced the following bill; which was 
 referred to the Committee on Oversight and Government Reform, and in 
 addition to the Committee on Energy and Commerce, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
   To provide for the issuance of a Lyme Disease Research Semipostal 
                                 Stamp.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Lyme Disease Research Stamp Act''.

SEC. 2. LYME DISEASE RESEARCH SEMIPOSTAL STAMP.

    (a) In General.--To afford a convenient way for members of the 
public to contribute to funding for Lyme disease and related tick-borne 
illness research within the National Institute of Allergy and 
Infectious Diseases, the United States Postal Service shall issue a 
semipostal stamp (hereinafter in this Act referred to as the ``Lyme 
Disease Research Semipostal Stamp'') in accordance with this section.
    (b) Terms and Conditions.--The issuance and sale of the Lyme 
Disease Research Semipostal Stamp shall be governed by the provisions 
of section 416 of title 39, United States Code, and regulations issued 
under such section.
    (c) Disposition of Proceeds.--
            (1) In general.--All amounts becoming available from the 
        sale of the Lyme Disease Research Semipostal Stamp (as 
        determined under section 416(d) of such title 39) shall be 
        transferred to the National Institute of Allergy and Infectious 
        Diseases, for the purpose described in subsection (a), through 
        payments which shall be made at least twice a year.
            (2) Proceeds not to be offset.--In accordance with section 
        416(d)(4) of such title 39, amounts becoming available from the 
        sale of the Lyme Disease Research Semipostal Stamp (as so 
        determined) shall not be taken into account in any decision 
        relating to the level of appropriations or other Federal 
        funding to be furnished in any year to the National Institute 
        of Allergy and Infectious Diseases.
    (d) Duration.--The Lyme Disease Research Semipostal Stamp shall be 
made available to the public for a period of at least 6 years, 
beginning no later than 12 months after the date of the enactment of 
this Act.
    (e) Definition.--For purposes of this Act, the term ``semipostal 
stamp'' refers to a stamp described in section 416(a)(1) of title 39, 
United States Code.
                                 <all>
```